We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Prime Minister Boris Johnson gave a statement at the coronavirus press conference.
First published during the 2019 to 2022 Johnson Conservative government
The vaccine will be made available across the UK to priority groups from next week.
…The first COVID-19 vaccine for the UK, developed by Pfizer/BioNTech, has today been given approval for use following a thorough review carried out by the Medicines and Healthcare products Regulatory Agency (MHRA).…
Government authorises first COVID-19 vaccine on independent advice of medicines regulator.
A technical and clinical evaluation has confirmed OptiGene RT-LAMP tests to be accurate and sensitive enough to be used for COVID-19 testing, including for those without symptoms.
The UK now has access to a total of 357 million doses of vaccines from 7 different developers.
…The government has formally asked the Medicines and Healthcare products Regulatory Agency to evaluate whether supply of Oxford/AstraZeneca vaccine can be authorised.…
UK’s independent regulator to evaluate latest data from Pfizer and BioNTech to ensure the quality, safety and effectiveness of the vaccine meets the standards required.
Vaccine could be delivered to the UK from Spring 2021.
Women using modafinil are being warned of an increased risk of birth defects associated with modafinil use during pregnancy.
We are reviewing the risks and benefits of the acne medicine, isotretinoin. In particular whether some of the possible psychiatric and sexual side effects continue after treatment has been stopped.
The Yellow Card scheme is the UK’s system for reporting suspected side effects to medicines and adverse events with medical devices run by the Medicines and Healthcare products Regulatory Agency (MHRA).
The MHRA’s Enforcement Group, working in collaboration with German law enforcement partners, has helped to dismantle a global criminal network involved in the illegal sale of medicines online.
Government announces restrictions on the export of supplies of flu vaccines to protect supplies for UK patients.
Users of Safe and Sound Infrared Ear Thermometers are being urged by the MHRA to check their product code and lot number due to a voluntary product recall of specific lots initiated by the company due to a fault.
US-licensed flu vaccine (Flublok) to be used as part of the UK’s 2020/21 seasonal flu programme
Over 30 million people to be vaccinated this year to protect them from flu and support the NHS.
The National Institute for Biological Standards and Control (NIBSC) will play a key role in evaluating vaccines that have been developed for COVID-19
£33.6 million government investment will back the studies in partnership with Imperial College London, hVIVO and the Royal Free London NHS Foundation Trust.
New laws will allow more healthcare workers to administer flu and potential COVID-19 vaccines safely to the public.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).